William McGivney, PhD

Managing Principal, McGivney Global Advisors
Co-Chair, AVBCC

Authored Items

The Rush to Value

July 2015, Vol 6, No 6 - VBCC Perspectives

The American Society of Clinical Oncology (ASCO) has introduced its conceptual framework to “Assess the Value of Cancer Treatment Options,” with the laudable objective to “assist physicians and patients in assessing the values of a new drug treatment.” As released, the ASCO framework has the potential to confound oncologists, in some instances, as follows. [ Read More ]